News
ATLANTA, September 30, 2024--Curant Health, a rare disease specialty pharmacy that improves health outcomes for rare and complex care patients, has been chosen by IntraBio as the exclusive ...
Contact 866-200-0419 to speak to an Aqneursa Cares team representative to seek assistance with any questions or concerns about access to Aqneursa. IntraBio Inc., a US biopharmaceutical company, is ...
Hosted on MSN8mon
Virginia family's unwavering fight helps secure FDA approval of life-saving drug: 'The next step is a cure' - MSNThe FDA recently authorized two drugs, MIPLYFFA (arimoclomol) and AQNEURSA (levacetylleucine) that are supposed to help stop the progression of the rare disease, Niemann-Pick Disease type C.
Hosted on MSN8mon
FDA Greenlights Aqneursa for Niemann-Pick Disease Type C, Marking a Breakthrough in Rare Disease Treatment - MSN— The U.S. Food and Drug Administration (FDA) has made a landmark decision to approve Aqneursa (levacetylleucine) for the treatment of neurological symptoms linked to Niemann-Pick disease type C … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback